125 related articles for article (PubMed ID: 1968233)
1. The role of alpha-2-adrenoceptors in the control of ACTH secretion; interaction with the opioid system.
al-Damluji S; Bouloux P; White A; Besser M
Neuroendocrinology; 1990 Jan; 51(1):76-81. PubMed ID: 1968233
[TBL] [Abstract][Full Text] [Related]
2. Blockade of alpha 2-adrenoceptors stimulates basal and stress-induced adrenocorticotropin secretion in the developing rat through a central mechanism independent from corticotropin-releasing factor and arginine vasopressin.
Grino M; Paulmyer-Lacroix O; Faudon M; Renard M; Anglade G
Endocrinology; 1994 Dec; 135(6):2549-57. PubMed ID: 7988443
[TBL] [Abstract][Full Text] [Related]
3. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the actions of tyrosine by alpha 2-adrenoceptor blockade.
Al-Damluji S; Ross G; Touzel R; Perrett D; White A; Besser GM
Br J Pharmacol; 1988 Oct; 95(2):405-12. PubMed ID: 2906556
[TBL] [Abstract][Full Text] [Related]
5. Alpha-2-adrenoceptor control of cortisol and ACTH in normal volunteers: preliminary open trial of the effects of acute and chronic idazoxan.
Glue P; Wilson S; Campling GM; Knightly M; Franklin M; Cowen PJ; Nutt DJ
Psychoneuroendocrinology; 1992; 17(2-3):261-6. PubMed ID: 1359600
[TBL] [Abstract][Full Text] [Related]
6. Peripheral pre and postjunctional alpha 2-adrenoceptors in man: studies with RX781094, a selective alpha 2 antagonist.
Elliott HL; Jones CR; Reid JL
J Hypertens Suppl; 1983 Dec; 1(2):109-11. PubMed ID: 6152738
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and haemodynamic effects of alpha 2-adrenoceptor stimulation and antagonism in man.
Brown MJ; Struthers AD; Di Silvio L; Yeo T; Ghatei M; Burrin JM
Clin Sci (Lond); 1985; 68 Suppl 10():137s-139s. PubMed ID: 2857610
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.
Brown MJ; Harland D
Br J Pharmacol; 1984 Nov; 83(3):657-65. PubMed ID: 6150737
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic and opioidergic modulation of a spinal reflex in the decerebrated rabbit.
Clarke RW; Ford TW; Taylor JS
J Physiol; 1988 Oct; 404():407-17. PubMed ID: 2908126
[TBL] [Abstract][Full Text] [Related]
10. Exercise-induced increases in plasma catecholamines and growth hormone are augmented by selective alpha 2-adrenoceptor blockade in man.
Struthers AD; Burrin JM; Brown MJ
Neuroendocrinology; 1986; 44(1):22-8. PubMed ID: 3024055
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the enantiomers of idazoxan: possible separation between their alpha-adrenoceptor blocking effects.
Dabire H; Dausse JP; Mouille P; Fournier B; Cardot A; Meyer P; Schmitt H
Clin Exp Hypertens A; 1986; 8(3):387-409. PubMed ID: 2873908
[TBL] [Abstract][Full Text] [Related]
12. Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetes.
Ostenson CG; Pigon J; Doxey JC; Efendic S
J Clin Endocrinol Metab; 1988 Nov; 67(5):1054-9. PubMed ID: 2903169
[TBL] [Abstract][Full Text] [Related]
13. Activation by high intensity peripheral nerve stimulation of adrenergic and opioidergic inhibition of a spinal reflex in the decerebrated rabbit.
Clarke RW; Ford TW; Taylor JS
Brain Res; 1989 Dec; 505(1):1-6. PubMed ID: 2558778
[TBL] [Abstract][Full Text] [Related]
14. Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.
Freedman JE; Aghajanian GK
Eur J Pharmacol; 1984 Oct; 105(3-4):265-72. PubMed ID: 6150858
[TBL] [Abstract][Full Text] [Related]
15. The effect of desipramine on basal and naloxone-stimulated cortisol secretion in humans: interaction of two drugs acting on noradrenergic control of adrenocorticotropin secretion.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
J Clin Endocrinol Metab; 1995 Mar; 80(3):802-6. PubMed ID: 7883833
[TBL] [Abstract][Full Text] [Related]
16. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man.
Delitala G; Trainer PJ; Oliva O; Fanciulli G; Grossman AB
J Endocrinol; 1994 Apr; 141(1):163-8. PubMed ID: 8031419
[TBL] [Abstract][Full Text] [Related]
17. (Imidazolinyl-2)-2-benzodioxane 1-4 (idazoxan) and its stereoisomers, new alpha 2-antagonists.
Dabiré H; Mouille P; Schmitt H
J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S127-9. PubMed ID: 2414573
[TBL] [Abstract][Full Text] [Related]
18. Involvement of alpha-2 adrenergic receptor subtypes in hyperglycemia.
Angel I; Niddam R; Langer SZ
J Pharmacol Exp Ther; 1990 Sep; 254(3):877-82. PubMed ID: 1975624
[TBL] [Abstract][Full Text] [Related]
19. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
20. Endogenous opioids may be involved in idazoxan-induced food intake.
Jackson HC; Griffin IJ; Nutt DJ
Neuropharmacology; 1992 Aug; 31(8):771-6. PubMed ID: 1356252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
